期刊文献+

125例双相情感障碍药物使用现况调查 被引量:4

Survey on medication treatment patterns in 125 patients with bipolar disorder
下载PDF
导出
摘要 目的调查河北省双相情感障碍患者精神药物的使用现况及3级(省级、市级、县级)医院精神科的处方差异。方法按一定的抽样比例,选取河北省37所精神疾病专科医院或综合医院精神科的125例双相情感障碍患者,于2007年11月19日至23日使用自制的调查问卷进行双相情感障碍处方方式的现况调查。结果 (1)125例患者中,躁狂相104例(83.2%),抑郁相21例(16.8%);123例(94.4%)患者接受精神药物治疗。(2)主要治疗药物为心境稳定剂98例(78.4%),抗精神病药89例(71.2%)。(3)躁狂相患者使用心境稳定剂(84.6%)和抗精神病药(79.8%)治疗为主,抑郁相患者使用抗抑郁药的频率较高(85.7%)。(4)市级医院抗抑郁剂的使用频率(32.8%)高于省级(4.8%)、县级(9.1%)医院(P<0.05)。结论河北省双相情感障碍精神药物的使用基本符合中国双相情感障碍防治指南,但在县、市级医院有使用不合理之处。建议进一步加强双相情感障碍防治指南的基层培训。 Objective To evaluate the use patterns of a medication treatment in the patients with bipolar disorder in Hebei province, and analyze the difference among the hospitals at 3 Cevels. Methods 125 patients with bipolar disorder were surveyed using the retested and revised self-made questionnaire, with the same sampling ratio, 37 hospitals in Hebei Province during 19th-23th, Nov, 2007. Results (1) The total number of sample was 125, including 104 (83.2%) patients with bipolar mania and 21 (16.8%) with bipolar depression, and 123 cases were treated with psychotropic drugs. (2) Most frequently prescribed was mood stabilizers (98 cases, 78.4%). 89 cases (71.2%) were treated with antipsychotic agents. (3) Bipola rmania were treated mainly with mood stabilizers (84.6%) and anfipsychotic agents (79.8%). Most patients with bipolar depression (85.7%) were treated with the antidepressants. (4) The frequently prescribed antidepressants in municipal hospitals (32.8%) was higher than in provincial hospitals (4.8%) and county hospitals (9.1%), (P〈0.05). Conclusion Medication prescription pattern for patients with bipolar disorder in Hebei province is in principle adherent to published practice guidelines, but high rate of antidepressants used in bipolar depression remains in clinical practice.Training of guidelines should be strengthed.
出处 《医学研究与教育》 CAS 2012年第4期23-27,共5页 Medical Research and Education
基金 河北省科学技术研究与发展计划项目(11276103D-41) 保定市科学技术研究与发展计划项目(ZF090)
关键词 双相情感障碍 抽样研究 处方药物 现状 bipolar disorder sampling study prescriptions drug actuality
  • 相关文献

参考文献11

二级参考文献102

  • 1司天梅,舒良,于欣,马崔,王高华,白培深,刘协和,纪丽萍,师建国,陈宪生,梅其一,栗克清,张鸿燕,马弘.10省市抗精神病药使用现况的调查[J].中华精神科杂志,2004,37(3):152-155. 被引量:95
  • 2王祖新.双相情感障碍的现代概念[J].中华医学信息导报,2004,19(6):21-21. 被引量:1
  • 3石其昌,章健民,徐方忠,费立鹏,许毅,傅永利,顾卫,周夏江,王淑敏,张滢,俞敏.浙江省15岁及以上人群精神疾病流行病学调查[J].中华预防医学杂志,2005,39(4):229-236. 被引量:297
  • 4金卫东,陈震.如何识别尚无躁狂发作的双相障碍?——介绍一种新概念:“软双相”[J].临床精神医学杂志,2005,15(4):249-250. 被引量:11
  • 5舒良主编.精神分裂症防治指南.北京:北京大学医学出版社.2007:127
  • 6dosReis S,Johnson E,Steinwachs D,et al.Antipsychotic treatment patterns and hospitalizations among adults with schizophrenia.Schizophr Res,2008,101:304-311.
  • 7Tandon R,Belmaker RH,Gattaz WF,et al.World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia.Schizophr Res,2008,100:20-38.
  • 8Hartung DM,Carlson M J,Kraemer DF,et al.Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.Med Care,2008,46:565-572.
  • 9Jano E,Johnson M,Chen H,et al.Determinants of atypical antipsychotic use among antipsychotic users in community-dwelling elderly,1996-2004.Curr Med Res Opin,2008,24:709-716.
  • 10Bitter I,Treuer T,Dyachkova Y,et al.Antipsychotic prescription patterns in outpatient settings:24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (ICSOHO) study.Eur Neuropsychopharmacol,2008,18:170-180.

共引文献194

同被引文献28

  • 1司天梅,舒良,于欣,马崔,王高华,白培深,刘协和,纪丽萍,师建国,陈宪生,梅其一,栗克清,张鸿燕,马弘.10省市双相情感障碍患者药物治疗的现况调查[J].中华精神科杂志,2005,38(3):165-169. 被引量:19
  • 2中华医学会.双相障碍防治指南[M].北京:北京大学医学出版社,2007:9-10;30-32.
  • 3世界卫生组织 范肖东 汪向东 于欣 等译.ICD-10精神与行为障碍分类[M].北京:人民卫生出版社,1993.38-57.
  • 4Moller H J, Nasrallah HA. Treatment of bipolar disorder[J]. J Clin Psychiatry, 2003, 64(Suppl 6): 9-17.
  • 5Trivedi JK, Sareen H, Yadav VS, et al. Prescription pattern of mood stabilizers for bipolar disorder at a tertiary health care centre in north India[J]. Indian J Psychiatry, 2013, 55(2): 131-134.
  • 6Fountoulakis KN, Kasper S, Andreassen O, et al. Efficacy of pharmaeotherapy in bipolar disorder: a report by the WPA see- tion on pharmaeopsyehiatry[J]. Eur Arch Psyehiatty Clin Neuro- sci, 2012, 262(Suppl 1): 1-48.
  • 7Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipo- lar disorder: update 2013[J]. Bipolar Disord, 2012, 15(1): 1-44.
  • 8Grunze H, Vieta E, Goodwin GM, et al. The World Federation of Societies of Biological Psyehiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression[J]. World J Biol Psychia- try, 2010, 11(2): 81-109.
  • 9Chang JS, Ha K. Management of bipolar depression[J]. Indian J Psyehol Med, 2011, 33(1): 11-17.
  • 10江琴普,栗克清,崔利军,杨老虎,李建峰,孙秀丽,高良会,韩彦超,刘永桥,严保平,张扬,杨保利,吕华,崔泽.河北省双相障碍的流行病学调查[J].现代预防医学,2008,35(16):3053-3055. 被引量:7

引证文献4

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部